CLB — Core Laboratories N.V. stock price, charts and financials

QT33Core Laboratories N.V.

Core Laboratories N.V. (NYSE: CLB) is a Energy company in the Oil & Gas Equipment & Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.95
+0.60+5.24%
CLBQT33Core Laboratories N.V.·NYSE
11.95+5.24%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index-P/E20.27EPS (ttm)0.56Insider Own13.02%Shs Outstand46.10MPerf Week6.67%
Market Cap523.20MForward P/E15.07EPS next Y0.75Insider Trans0.08%Shs Float45.24MPerf Month3.28%
Enterprise Value665.58MPEG-EPS next Q0.18Inst Own-Short Float8.89%Perf Quarter-15.61%
Income23.96MP/S1.01EPS this Y-16.24%Inst Trans-Short Ratio5.19Perf Half Y-39.56%
Sales519.17MP/B1.95EPS next Y60.58%ROA4.15%Short Interest4.02MPerf YTD-29.20%
Book/sh-P/C18.85EPS next 5Y48.37%ROE9.03%52W High21.43 -44.25%Perf Year10.30%
Cash/sh-P/FCF48.76EPS past 3/5Y17.42% -ROIC6.48%52W Low10.23 16.77%Perf 3Y-56.31%
Dividend Est.0.04 (0.33%)EV/EBITDA10.62Sales past 3/5Y2.46% 1.59%Gross Margin18.12%Volatility4.74% 5.14%Perf 5Y-65.98%
Dividend TTM0.03 (0.25%)EV/Sales1.28EPS Y/Y TTM-15.15%Oper. Margin9.25%ATR (14)0.59Perf 10Y-90.25%
Dividend Ex-DateAug 10, 2026Quick Ratio1.55Sales Y/Y TTM-0.76%Profit Margin4.69%RSI (14)50.80Recom2.68
Dividend Gr. 3/5Y0.00% -32.24%Current Ratio2.12EPS Q/Q-42.11%SMA201.61%Beta1.06Target Price25.00
Payout7.60%Debt/Eq0.61Sales Q/Q-3.85%SMA50-3.80%Rel Volume0.46Prev Close11.35
Employees3,300LT Debt/Eq0.56EarningsOct 28SMA200-26.00%Avg Volume839.96KPrice11.95
IPO DateSep 21, 1995Option/ShortYes / YesEPS/Sales Surpr.26.62% -1.31%Net Debt/EBITDA2.27Volume387,962Change5.24%
Analyst Ratings
DateActionAnalystRatingTarget
Mar-12-25UpgradeCitigroupSellNeutral
Jul-15-24ReiteratedPiper SandlerNeutral$18$17
Apr-18-23DowngradeB of A SecuritiesNeutralUnderperform
Feb-07-23ReiteratedCitigroupNeutral$26
Jan-09-23UpgradeB of A SecuritiesUnderperformNeutral
Oct-07-22UpgradeCitigroupSellNeutral
Sep-26-22DowngradeMorgan StanleyEqual WeightUnderweight
May-02-22ReiteratedMorgan StanleyEqual Weight$32
Apr-18-22DowngradePiper SandlerNeutralUnderweight
Oct-18-21DowngradeB of A SecuritiesNeutralUnderperform
Latest News
Jul-31-26
Jul-30-26
Jul-29-26
Jul-23-26
Jul-22-26
Jul-20-26
Jul-02-26
Jun-30-26
Jun-26-26
Company

Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue520527524
Cost of Goods Sold Incl. D&A424432435
Gross Profit949488
Selling, General and Administrative Excl. Other464439
Research and Development
000
Other Operating Expense00-9
Operating Income485059
Interest Expense121112
Unusual Expense
Non-Operating Income (Expense)060
Net Income Before Taxes364646
Income Taxes131614
Consolidated Net Income243031
Net Income From Continuing Operations253032
Net Income243031
EPS (Recurring)0.560.680.67
EPS (Basic, Before Extraordinaries)0.560.680.67
EPS (Diluted)0.560.680.66
EBITDA647174
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio21.3323.5726.23
Price To Sales Ratio1.081.431.55
Gross Margin18.0817.8416.79
Operating Margin9.239.4911.26
Net Margin4.625.695.92
Shares Outstanding474747
Market Capitalization561753814
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$21.16$17.93$14.71$11.48$8.25 Close Price0.00K13.47K26.95K40.42K53.90KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Teo Sow HangCAO & TreasurerAug 01 '26Option Exercise0.0044008,775Aug 04
Tattoli Mark DamianSVP, Gen Counsel & SecretaryAug 01 '26Option Exercise0.00250027,764Aug 04
Bruno LawrenceChairman and CEOJul 31 '26Buy10.785,00053,900262,438Aug 04
Tattoli Mark DamianSVP, Gen Counsel & SecretaryMay 01 '26Option Exercise0.00250027,611May 04
Murray KatherineDirectorApr 01 '26Option Exercise0.008,069029,290Apr 08
ANASTASIO CURTDirectorApr 01 '26Option Exercise0.008,069023,805Apr 07
Klingensmith Harvey RobertDirectorApr 01 '26Option Exercise0.008,069050,031Apr 07
Temeng KwakuDirectorApr 01 '26Option Exercise0.008,069033,597Apr 07
MARTINOVICH ROBERT FDirectorApr 01 '26Option Exercise0.008,06908,069Apr 07
Carnes Martha Z.DirectorApr 01 '26Option Exercise0.008,069054,397Apr 07
Tattoli Mark DamianSVP, Gen Counsel & SecretaryDec 31 '25Option Exercise0.0024,952041,671Jan 05
Gresham GwendolynSVPDec 31 '25Option Exercise0.0024,952052,527Jan 05
Hill Christopher ScottSVP & CFODec 31 '25Option Exercise0.0061,4170142,354Jan 05
Bruno LawrenceChairman and CEODec 31 '25Option Exercise0.00180,7220370,119Jan 05
Teo Sow HangCAO & TreasurerDec 01 '25Option Exercise0.0086408,765Dec 02
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.